EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3 TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI
2021
Pedro Cahn | Juan Sierra Madero | José Ramón Arribas | Jörg Sievers | Choy Man | Rimgaile Urbaityte | Mark Underwood | Jean Andre Van Wyk | Kimberly Smith | Roberto Zajdenverg
Bibliographic information
Brazilian Journal of Infectious Diseases
Volume
25
Pagination
101259
ISSN
1413-8670
Publisher
Elsevier
Language
English
2024-12-11
DOAJ
Data Provider
This bibliographic record has been provided by Directory of Open Access Journals
If you notice any incorrect information relating to this record, please contact us at agris@fao.org
